Global

Medicine Experts

Peter Ratcliffe


Medicine
Francis Crick Institute
United Kingdom

Biography

Peter Ratcliffe is a physician scientist who trained in medicine at Gonville and Caius College, Cambridge and St. Bartholomew's Hospital, London, before moving to Oxford to specialise in renal medicine. After studying the physiology of renal circulation, he became interested in the regulation of the haematopoietic growth factor erythropoietin, which is produced by the kidneys in response to reduced blood oxygen availability.  In 1990, with funding as a Wellcome Trust Senior Fellow, he set up the Hypoxia Biology laboratory in the Weatherall Institute of Molecular Medicine, Oxford. Peter was elected to the Fellowship of the Royal Society and to the Academy of Medical Sciences in 2002. He is a member of EMBO and a foreign honorary member of the American Academy of Arts and Sciences. His work on oxygen sensing has won a number of awards including the Louis-Jeantet Prize in Medicine, the Canada Gairdner International Award, and the Lasker Award for Basic Biomedical Research. He was knighted for services to medicine in the New Year's Honours, 2014.

Research Interest

Peter's current research aims to understand the biological roles of signalling through protein hydroxylation and related oxidations. he became interested in the regulation of the haematopoietic growth factor erythropoietin, which is produced by the kidneys in response to reduced blood oxygen availability.

Publications

  • Pugh, CW and Ratcliffe, PJ (2017) New horizons in hypoxia signaling pathways. Experimental Cell Research 356, 116-121

  • Paolini, NA; Attwood, M; Sondalle, SB; Vieira, CMDS; van Adrichem, AM; di Summa, FM; O'Donohue, M-F; Gleizes, P-E; Rachuri, S; Briggs, JW; Fischer, R; Ratcliffe, PJ; Wlodarski, MW; Houtkooper, RH; von Lindern, M; Kuijpers, TW; Dinman, JD; Baserga, SJ; Cockman, ME and MacInnes, AW (2017) A ribosomopathy reveals decoding defective ribosomes driving human dysmorphism. American Journal of Human Genetics 100, 506-522

  • Grampp, S; Schmid, V; Salama, R; Lauer, V; Kranz, F; Platt, JL; Smythies, J; Choudhry, H; Goppelt-Struebe, M; Ratcliffe, PJ; Mole, DR and Schödel, J (2017) Multiple renal cancer susceptibility polymorphisms modulate the HIF pathway. PLOS Genetics 13, e1006872

Global Experts from United Kingdom

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America